Separate efforts to remove the medical cannabis program and legalize recreational cannabis in South Dakota are proposed to appear on the 2024 ballot.
Medical cannabis was approved in the state in 2020 with nearly 70% of voters in favor after two previous failed ballot measures, and sales of medical cannabis began in July 2022 (1,2). Cannabis for recreational use was also approved at the time, but was subsequently overturned the following year by a state Supreme Court decision (1). In 2022, voters rejected a separate initiative on the ballot (3).
In July 2023, a South Dakotan activist submitted a proposal for a ballot initiative to repeal the state’s recently introduced medical cannabis program (1). The Secretary of the State received a draft of the proposed initiative on July 27th from Attorney General Marty Jackley, and a final summary was submitted on August 14th (3,4). The final summary read (5):
“In the 2020 General Election, the voters approved the creation of the South Dakota medical marijuana program. By approving that program, the voters legalized the possession, use, cultivation, manufacture, and sale of marijuana and marijuana products, under certain conditions, for medical purposes.
This initiated measure repeals South Dakota’s medical marijuana program. If approved, that repeal makes all possession, use, cultivation, manufacture, and sale of marijuana and marijuana products a crime.
This initiated measure does not affect laws dealing with hemp. Marijuana remains illegal under Federal law.”
The final summary included several emails addressed to “ATG Ballot Comments” stating positions for and against the proposed ballot measure (5). The public had been given until August 6th to submit comments (1).
The measure needs more than 17,000 signatures from registered voters to qualify for the 2024 ballot (1).
A few days before submitting this final summary, the Attorney General’s office submitted a draft of an initiative that would put the recreational cannabis on the ballot once again (6). This initiative intends to allow adults over 21 to possess, grow, sell, and distribute cannabis and cannabis products, and claims to not affect laws concerning hemp or the medical cannabis program (6).
References
Best of the Week: June 13 – June 19, 2025
June 20th 2025Here, we bring you our top five recent articles covering medical cannabis in Hawaii, a new dispensary in Connecticut, pesticide testing in California, a cease-and-desist letter to a dispensary on Long Island, and a global survey on cannabis for endometriosis.
Global Survey Examines Cannabis Use over Pharmaceuticals for Endometriosis Symptom Relief
June 17th 2025A survey of nearly 900 endometriosis patients across 28 countries highlights cannabis as a preferred alternative to pharmaceuticals, despite legal, social, and medical communication barriers.
Best of the Week: June 6 – June 12, 2025
June 13th 2025Here, we bring you our top five recent articles covering safety regulations in North Carolina, licenses in Minnesota, the FDA’s FY2026 Agriculture appropriations bill, cannabis taxes in California, and antifungal properties of CBD and CBDV.